Aptose Biosciences Stock Today
| APS Stock | CAD 1.66 0.01 0.61% |
Performance0 of 100
| Odds Of DistressOver 88
|
Aptose Biosciences is selling at 1.66 as of the 24th of April 2024; that is 0.61 percent up since the beginning of the trading day. The stock's open price was 1.65. Aptose Biosciences has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Aptose Biosciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in the United States. Aptose Biosciences Inc. was founded in 1986 and is headquartered in Toronto, Canada. The company has 15.72 M outstanding shares of which 18.3 K shares are presently shorted by private and institutional investors with about 1.24 days to cover all short positions. More on Aptose Biosciences
Moving together with Aptose Stock
| 0.79 | THRM | Therma Bright | PairCorr |
| 0.79 | FUND | Katipult Technology Corp | PairCorr |
| 0.78 | QBR-A | Quebecor | PairCorr |
Moving against Aptose Stock
| 0.93 | CNQ | Canadian Natural Res Earnings Call Next Week | PairCorr |
| 0.88 | ARX | ARC Resources Earnings Call Next Week | PairCorr |
| 0.87 | IVN | Ivanhoe Mines Earnings Call This Week | PairCorr |
| 0.57 | BHC | Bausch Health Companies Earnings Call Next Week | PairCorr |
| 0.49 | GLXY | Galaxy Digital Holdings | PairCorr |
| 0.44 | TXT-UN | Top 10 Split | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Aptose Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Aptose Biosciences' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Aptose Biosciences or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman, CEO and Pres | William Rice | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
Aptose Biosciences' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Aptose Biosciences' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Aptose Biosciences' financial leverage. It provides some insight into what part of Aptose Biosciences' total assets is financed by creditors.
| |||||
Aptose Biosciences (APS) is traded on Toronto Exchange in Canada and employs 35 people. Aptose Biosciences is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 25.93 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aptose Biosciences's market, we take the total number of its shares issued and multiply it by Aptose Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Aptose Biosciences operates under Biotechnology sector and is part of Health Care industry. The entity has 15.72 M outstanding shares of which 18.3 K shares are presently shorted by private and institutional investors with about 1.24 days to cover all short positions.
Aptose Biosciences has accumulated about 36.37 M in cash with (44.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.64.
Check Aptose Biosciences Probability Of Bankruptcy
Ownership AllocationAptose Biosciences holds a total of 15.72 Million outstanding shares. Aptose Biosciences shows 19.71 percent of its outstanding shares held by insiders and 7.6 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Aptose Ownership Details
Aptose Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Aptose Biosciences jumping above the current price in 90 days from now is over 95.99%. The Aptose Biosciences probability density function shows the probability of Aptose Biosciences stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Aptose Biosciences has a beta of 0.2818. This suggests as returns on the market go up, Aptose Biosciences average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Aptose Biosciences will be expected to be much smaller as well. Additionally, aptose Biosciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Aptose Biosciences to move above the current price in 90 days from now is over 95.99 (This Aptose Biosciences probability density function shows the probability of Aptose Stock to fall within a particular range of prices over 90 days) .
Aptose Biosciences Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Aptose Biosciences market risk premium is the additional return an investor will receive from holding Aptose Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Aptose Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Aptose Biosciences' alpha and beta are two of the key measurements used to evaluate Aptose Biosciences' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.0 | |||
| Standard Deviation | 3.76 | |||
| Variance | 14.1 | |||
| Risk Adjusted Performance | (0.12) |
Aptose Stock Against Markets
Picking the right benchmark for Aptose Biosciences stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Aptose Biosciences stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Aptose Biosciences is critical whether you are bullish or bearish towards Aptose Biosciences at a given time. Please also check how Aptose Biosciences' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Aptose Biosciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Global Correlations Now
Global CorrelationsFind global opportunities by holding instruments from different markets |
| All Next | Launch Module |
Aptose Biosciences Corporate Directors
Aptose Biosciences corporate directors refer to members of an Aptose Biosciences board of directors. The board of directors generally takes responsibility for the Aptose Biosciences' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Aptose Biosciences' board members must vote for the resolution. The Aptose Biosciences board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Denis Burger | Independent Director | Profile | |
| Warren Whitehead | Independent Director | Profile | |
| Bradley Thompson | Independent Director | Profile | |
| Erich Platzer | Director | Profile |
How to buy Aptose Stock?
Before investing in Aptose Biosciences, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Aptose Biosciences. To buy Aptose Biosciences stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Aptose Biosciences. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Aptose Biosciences stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Aptose Biosciences stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Aptose Biosciences stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Aptose Biosciences, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Aptose Stock please use our How to Invest in Aptose Biosciences guide.
Already Invested in Aptose Biosciences?
The danger of trading Aptose Biosciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aptose Biosciences is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aptose Biosciences. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aptose Biosciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Aptose Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aptose Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aptose Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aptose Biosciences Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptose Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Aptose Stock analysis
When running Aptose Biosciences' price analysis, check to measure Aptose Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aptose Biosciences is operating at the current time. Most of Aptose Biosciences' value examination focuses on studying past and present price action to predict the probability of Aptose Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aptose Biosciences' price. Additionally, you may evaluate how the addition of Aptose Biosciences to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |